Search Results
Jul 15, 2025, 17:31 ET Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight
Overview Menin is a unique scaffold protein located in the cell nucleus and is encoded by the MEN1 (Menin 1) gene, a well-established tumor suppressor. Mutations in the MEN1 gene are widely recognized for their role in causing sporadic or inherited (autosomal dominant) endocrine tumor syndromes,
More news about: DelveInsight Business Research, LLP
Jul 15, 2025, 16:06 ET ATTENTION NASDAQ: RCKT INVESTORS: Contact Berger Montague About a Rocket Pharmaceuticals Class Action Lawsuit
New Jersey and alleges that the Company misled investors regarding critical safety disclosures tied to its RP-A501 gene therapy program.
More news about: Berger Montague
Jul 15, 2025, 11:25 ET RESEARCH SHOWS EARLY CANCER CELLS CAN BE RAPIDLY DETECTED THROUGH ELECTRONIC SEMICONDUCTORS
could be a major breakthrough in widescale early screening and diagnosis for some of the most predominant forms of the disease." Check4 is a gene-detection platform that is built around a reusable portable Bluetooth device and a single-use cartridge that accepts both saliva and blood samples to
More news about: IdentifySensors Biologics
Jul 15, 2025, 09:00 ET Investors who lost money on Sarepta Therapeutics, Inc.(SRPT) should contact Levi & Korsinsky about pending Class Action - SRPT
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) ELEVIDYS, a prescription gene therapy for Duchenne, posed significant safety risks to patients; (ii) ELEVIDYS trial regimes and protocols failed to detect severe side effects; (iii)
More news about: Levi & Korsinsky, LLP
Jul 15, 2025, 08:30 ET Neurocrine Biosciences Presents New Analysis of CAHtalog® Registry Showing Most Patients with Classic Congenital Adrenal Hyperplasia Experienced High Glucocorticoid Exposure, Suboptimal Disease Control or Both at ENDO 2025
adrenal steroid hormones, such as cortisol, aldosterone and adrenal androgens. Approximately 95% of CAH cases are caused by variants of the CYP21A2 gene that leads to deficiency of the enzyme 21-hydroxylase. Severe deficiency of this enzyme leads to an inability of the adrenal glands to produce enough
More news about: Neurocrine Biosciences, Inc.
Jul 15, 2025, 07:30 ET Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity
the treatment of leptin receptor (LEPR) deficiency-related obesity, a rare genetic disorder that disrupts MC4R signaling due to mutations in the LEPR gene. The leptin-melanocortin pathway, located in the hypothalamus, regulates hunger, energy balance, and body weight. Individuals with LEPR deficiency often
More news about: Palatin Technologies, Inc.
Jul 15, 2025, 07:00 ET Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors
American Association for Cancer Research, California Institute for Regenerative Medicine, California Breast Cancer Research Program, Bionano Genomics, Sio Gene Therapies, Forian, Inhibrx and WebMD (acquired by Internet Brands). Dr. Vuori received her M.D. and Ph.D. from the University of Oulu, Finland
More news about: Tract Bio
Jul 14, 2025, 16:35 ET Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society's Annual Meeting
adrenal steroid hormones, such as cortisol, aldosterone and adrenal androgens. Approximately 95% of CAH cases are caused by variants of the CYP21A2 gene that leads to deficiency of the enzyme 21-hydroxylase. Severe deficiency of this enzyme leads to an inability of the adrenal glands to produce enough
More news about: Neurocrine Biosciences, Inc.
Jul 14, 2025, 13:32 ET Golden State Dermatology Expands in Greater Los Angeles with Acquisition of Two-Location Practice
July 14, 2025 /PRNewswire/ -- Golden State Dermatology (GSD) is pleased to announce a new partnership with Dr. Gene Rubinstein's practice, LAskinMD with locations in Studio City and Simi Valley:
More news about: Golden State Dermatology
Jul 14, 2025, 11:07 ET Regrowing hearing cells: New gene functions discovered in zebrafish offer clues for future hearing loss treatments
blood." Progenitor cells lacking their cell type-specific cyclinD gene did not proliferate; however, they did form a hair cell, uncoupling cell division with differentiation. Notably, when the stem cell-specific cyclinD gene was engineered to work in progenitor cells, progenitor cell division was
More news about: Stowers Institute for Medical Research
Jul 14, 2025, 10:18 ET GreenPal Empowers Lawn Care Pros Leveraging AI, Surpasses 5 Million Transactions
visit GreenPal.com Media Contact:Gene [email protected] Photo(s):
More news about: GreenPal Co
Jul 14, 2025, 09:00 ET The Gross Law Firm Notifies Sarepta Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SRPT
during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) ELEVIDYS, a prescription gene therapy for Duchenne, posed significant safety risks to patients; (ii) ELEVIDYS trial regimes and protocols failed to detect severe side effects; (iii)
More news about: The Gross Law Firm
Jul 14, 2025, 08:30 ET Viome and Scripps Research Partner to Develop First At-home RNA Screening Test to Prevent Colon Cancer Before It Strikes
cohort of healthy patients undergoing routine gastrointestinal exams. Leveraging Viome's RNA sequencing and AI platform, trained on the world's largest gene expression database, the test seeks to identify molecular signals years before standard screenings. "Colorectal cancer remains one of the deadliest
More news about: Viome Life Sciences
Jul 14, 2025, 08:30 ET Neurocrine Biosciences Presents One-Year Data Showing Sustained Efficacy of CRENESSITY® (crinecerfont) in Adult Patients, at ENDO 2025
adrenal steroid hormones, such as cortisol, aldosterone and adrenal androgens. Approximately 95% of CAH cases are caused by variants of the CYP21A2 gene that leads to deficiency of the enzyme 21-hydroxylase. Severe deficiency of this enzyme leads to an inability of the adrenal glands to produce enough
More news about: Neurocrine Biosciences, Inc.
Jul 14, 2025, 07:00 ET Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona's ZEVASKYN™ (prademagene zamikeracel) is the first and only autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic
More news about: Bio-Techne Corporation
Jul 14, 2025, 07:00 ET Nanoscope Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for MCO-010, the First Gene-Agnostic Therapy to Treat Retinitis Pigmentosa
This marks a significant regulatory milestone as the first BLA submitted for a gene-agnostic gene therapy for retinal disease. Being gene-agnostic means that MCO-010 is designed to address the broad genetic diversity of RP—a condition linked to over
More news about: Nanoscope Therapeutics
Jul 14, 2025, 02:43 ET MGI Tech Won Green World Award for Sustainable Contribution to Thai Mangroves Conservation Efforts
after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to
More news about: MGI Tech
Jul 14, 2025, 02:07 ET MGI Tech Won Green World Award for Sustainable Contribution to Thai Mangroves Conservation Efforts
after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to
More news about: MGI Tech
Jul 13, 2025, 15:00 ET SRPT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Class Period, Sarepta was engaged in the development of therapies to treat Duchenne muscular dystrophy ("Duchenne"), including ELEVIDYS (a prescription gene therapy intended for a limited category of people with Duchenne). The Sarepta Therapeutics class action lawsuit alleges that
More news about: Robbins Geller Rudman & Dowd LLP
Jul 12, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
action] On May 27, 2025, Rocket issued a press release "announc[ing] an update related to RP-A501, its investigational gene therapy for Danon disease." The press release disclosed that "[a] patient participating in the Phase 2 pivotal trial of RP-A501 experienced an unexpected
More news about: Pomerantz LLP
Jul 12, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
dystrophy ("DMD"), a genetic disorder characterized by progressive muscle degeneration and weakness. DMD is caused by the mutation of the dystrophin gene, resulting in, inter alia, a limited production of the dystrophin protein, which in turn leads to DMD's clinical features. According to PepGen,
More news about: Pomerantz LLP
Jul 12, 2025, 08:26 ET SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit
the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) ELEVIDYS, a prescription gene therapy intended for certain patients being treated for Duchenne muscular dystrophy, posed significant safety risks to patients; (2) ELEVIDYS trial
More news about: THE ROSEN LAW FIRM, P. A.
Jul 11, 2025, 11:21 ET Conheça os procedimentos estéticos que estão em alta para regenerar a pele
Calame et al. Histological changes with extracellular matrix-remodeling topical therapy. Dermatol Case Rep 2017.22. Widgerow et al. Gene expression studies on extracellular matrix integrity: in vitro nuances. J Drugs Dermatol 2019.23. Widgerow AD, Jiang LI, Calame
More news about: Galderma
Jul 11, 2025, 09:00 ET Sarepta Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - SRPT
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) ELEVIDYS, a prescription gene therapy for Duchenne, posed significant safety risks to patients; (ii) ELEVIDYS trial regimes and protocols failed to detect severe side effects; (iii)
More news about: Levi & Korsinsky, LLP
Jul 11, 2025, 06:12 ET June in Review: 14 Top Health Press Releases
– Replace a Silenced Gene Called Alpha-Klotho ("α- KLOTHO") Recent clinical and pre-clinical studies and analysis indicates the potential to increase lifespan and reduce age-associated degeneration in multiple organ systems has be realized with a focus on the human gene called Klotho.
More news about: PR Newswire